Navigation Links
Scientists Warn of Long Term Consequences of Budget Sequestration: BioInformatics LLC Report
Date:2/27/2013

Arlington, VA (PRWEB) February 27, 2013

Life scientists responding to a recent survey warned Congress and the Administration that the impending budget sequestration could have grave consequences for the future of biological and medical research in the U.S. “The need for well-educated scientists in the U.S. is often discussed as being a priority with both the Administration and Congress. What better way to deter potential researchers than to continuously cut or keep static funding to the life sciences?" asks Kathryn Scott, a Laboratory Manager at a leading university medical center. "Spending needs to be controlled; however, the need to keep the best and brightest in science and technology is greater. Cutting funding will deter those considering careers in the life sciences and those already employed as scientists to look elsewhere for a use of their talents.”

BioInformatics LLC, the premier research and advisory firm in the life science industry, conducted a survey of U.S. academic, government and pharmaceutical scientists to gauge the impact of the planned cutbacks in federal funding for research and their implications for life science tools companies. The free report can be downloaded here:

Life Scientist Reactions to the Impending Budget Sequestration

“69% of U.S. life scientists expect that sequestration will have a ‘substantial impact’ on their research,” says Bill Kelly, President of BioInformatics LLC. “When we asked about the immediate effects they expect as the result of the sequester, scientists across all market segments predict the cutbacks will limit their ability to hire new staff for their labs, obtain new grants and attend scientific conferences.”

Life science tools companies can expect lower sales as a near-term reaction to the budget sequestration. But the situation is unlikely to be as dire as some have feared. “Assuming funding is not restored quickly, surprisingly, only one-quarter of academic and government life science labs say they will consider deferring or postponing capital equipment and/or instrument purchases this year," says Kelly.

Instead, other actions taken as a result of sequestration—such as hiring freezes, lab closings, project cancellations or reductions in new labs—are likely to have a longer lasting effect on the life science market. “Scientific research isn’t something that can be turned on and off – it’s a long term investment,” says Kelly. “Budget uncertainty begins to erode the supporting infrastructure, drives researchers out of the field and threatens the U.S. leadership position in the biosciences.”

ABOUT BIOINFORMATICS LLC

BioInformatics LLC is the premier research and advisory firm serving the life science industry. By leveraging our professional social network of more than 72,000 life scientists, we have supported more than 500 companies and provided insights that lead to better business decisions. Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10475234.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Scientists defuse the Vietnam time bomb
2. Singapore scientists lead human embryonic stem cell study
3. Sheffield scientists shine a light on the detection of bacterial infection
4. Nanowiggles: Scientists discover graphene nanomaterials with tunable functionality in electronics
5. Scientists solve mystery of colorful armchair nanotubes
6. iBioSeminars and iBioMagazine: Free, Online Biology Seminars and Short Talks by Leading Scientists
7. Chinese Scientists Zhen-Yi Wang and Zhu Chen Awarded 7th Annual Szent-Gyorgyi Prize for Progress in Cancer Research
8. Scientists decode brain waves to eavesdrop on what we hear
9. Receptos Scientists Publish Determination of a High Resolution Sphingosine 1-Phosphate Receptor 1 Structure in Science
10. Scientists learn how to out run damage with imaging technique
11. Design eye for the science guy: Drop-in clinic helps scientists communicate data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... June 27, 2016   Ginkgo Bioworks , a ... engineering, was today awarded as one of the ... the world,s most innovative companies. Ginkgo Bioworks is ... the real world in the nutrition, health and ... directly with customers including Fortune 500 companies to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle ... people with peritoneal or pleural mesothelioma. Their findings are the subject of a new ... , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
Breaking Biology Technology:
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
Breaking Biology News(10 mins):